GB0016563D0 - Pharmaceutical - Google Patents

Pharmaceutical

Info

Publication number
GB0016563D0
GB0016563D0 GB0016563A GB0016563A GB0016563D0 GB 0016563 D0 GB0016563 D0 GB 0016563D0 GB 0016563 A GB0016563 A GB 0016563A GB 0016563 A GB0016563 A GB 0016563A GB 0016563 D0 GB0016563 D0 GB 0016563D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0016563A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0016563A priority Critical patent/GB0016563D0/en
Publication of GB0016563D0 publication Critical patent/GB0016563D0/en
Priority claimed from IL13945600A external-priority patent/IL139456D0/en
Priority claimed from US10/686,349 external-priority patent/US20050070499A1/en
Application status is Ceased legal-status Critical

Links

GB0016563A 2000-07-05 2000-07-05 Pharmaceutical Ceased GB0016563D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0016563A GB0016563D0 (en) 2000-07-05 2000-07-05 Pharmaceutical

Applications Claiming Priority (84)

Application Number Priority Date Filing Date Title
GB0016563A GB0016563D0 (en) 2000-07-05 2000-07-05 Pharmaceutical
IL13945600A IL139456D0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945500A IL139455D0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945400A IL139454D0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945700A IL139457D0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
EP20000309720 EP1097718A1 (en) 1999-11-08 2000-11-03 NPY antagonists for the treatment of female sexual dysfunction
EP20040020972 EP1481667A1 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual dysfunction
EP00309722A EP1097719B1 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual dysfunction
DK00309722T DK1097719T3 (en) 1999-11-08 2000-11-03 Use of compounds for the treatment of female sexual dysfunction
EP00309718A EP1097706A1 (en) 1999-11-08 2000-11-03 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
PT00309722T PT1097719E (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
ES00309722T ES2233297T3 (en) 1999-11-08 2000-11-03 Inhibitors of the neutral endopeptidase (nep) for the treatment of female sexual dysfunction.
SK1672-2000A SK16722000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
EP20000309719 EP1097707A1 (en) 1999-11-08 2000-11-03 Treatment of female sexual dysfunction
DE60016877T DE60016877T2 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual disorders
SK1671-2000A SK16712000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
AT00309722T AT285249T (en) 1999-11-08 2000-11-03 Nep inhibitors for the treatment of female sexual disorders
SK1670-2000A SK16702000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
CZ20004110A CZ20004110A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
AU71411/00A AU781186B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
CZ20004107A CZ20004107A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
CZ20004106A CZ20004106A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
AU71408/00A AU781403B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
MYPI20005205A MY140534A (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
AU71407/00A AU781400B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
AU71409/00A AU7140900A (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
MYPI20005202A MY141651A (en) 1999-11-08 2000-11-06 Nep inhibitors for the treatment of female sexual dysfunction
CN00137670A CN1328824A (en) 1999-11-08 2000-11-07 Compound for curing female sexual disorder
CO00084521A CO5680109A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001186A PE20010924A1 (en) 1999-11-08 2000-11-07 Phosphodiesterase inhibitor compounds useful for the treatment of female sexual dysfunction
HU0004347A HU0004347A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
KR1020000065740A KR20010051481A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
NZ508012A NZ508012A (en) 1999-11-08 2000-11-07 Compounds that potentiate cAMP and is an inhibitor of NEP (neutral endopeptidase) (enkaplinhalinase)
CO00084519A CO5680108A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
HU0004348A HU0004348A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
NO20005661A NO20005661L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
NZ508011A NZ508011A (en) 1999-11-08 2000-11-07 Compounds that inhibit phosphodiesterase activity which results in potentiation of cAMP or cGMP to promote smooth muscle vasodilation
PE2000001185A PE20010817A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CN00137665A CN1320426A (en) 1999-11-08 2000-11-07 Compound for treatment of female sexual dysfuction
CNA2004100713908A CN1575816A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CN00137671A CN1322526A (en) 1999-11-08 2000-11-07 Compound for treating female sexual dysfunction
NO20005618A NO20005618L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
HU0004349A HU0004349A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CA002324484A CA2324484A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
NZ508007A NZ508007A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction that potentiate cAMP activity and is an inhibitor of neuropeptide-Y (NPY)
NO20005662A NO20005662L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
CA002323191A CA2323191A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
KR1020000065868A KR20010086267A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
CA002323183A CA2323183A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CA002323464A CA2323464A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
HU0004350A HU0004350A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001187A PE20010926A1 (en) 1999-11-08 2000-11-07 Endopeptidase inhibitor compounds useful for the treatment of female sexual dysfunction
KR1020000065863A KR20010082545A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
PE2000001188A PE20010925A1 (en) 1999-11-08 2000-11-07 Neuropeptide inhibiting compounds and useful for the treatment of female sexual dysfunction
KR1020000065761A KR20010082544A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
BR0005266-3A BR0005266A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
NZ508006A NZ508006A (en) 1999-11-08 2000-11-07 Compounds that potentiate cAMP responses for treatment of female impotence
CNA2004100859558A CN1636597A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
EA200001042A EA200001042A3 (en) 1999-11-08 2000-11-08 Connections for the treatment of female sexual dysfunction
PL00343754A PL343754A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
EA200001043A EA006254B1 (en) 1999-11-08 2000-11-08 I:npy inhibitor for treating female sexual dysfunction
JP2000339957A JP2001247479A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
JP2000339905A JP2001206855A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
PL00343753A PL343753A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agend, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
BR0005299-0A BR0005299A (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
JP2000339853A JP2001213802A (en) 1999-11-08 2000-11-08 Compound for treating female sexual dysfunction
US09/708,392 US6734186B1 (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
PL00343755A PL343755A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agend, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
EA200001044A EA006242B1 (en) 1999-11-08 2000-11-08 Nep inhibitors for the treatment of female sexual disfunction
JP2000339949A JP2001247478A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
BR0005276-0A BR0005276A (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
US10/686,349 US20050070499A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
US10/686,390 US20040254153A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
US10/686,282 US20050020547A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
KR1020040050973A KR20040074023A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050972A KR20040074022A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050971A KR20040074021A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
JP2004267669A JP2005021167A (en) 1999-11-08 2004-09-15 Assay method for identifying agent for treating female sexual dysfunction (fsd), method and kit for detecting female sexual dysfunction and non-human animal model of female sexual dysfunction
JP2004268608A JP2005013237A (en) 1999-11-08 2004-09-15 Assaying method for identifying agent for treating female sexual dysfunction (fsd), method and kit for detecting female sexual dysfunction, and non-human animal model of female sexual dysfunction
JP2004269807A JP2005043377A (en) 1999-11-08 2004-09-16 Medicine for treating female sexual dysfunction
JP2004269732A JP2005070055A (en) 1999-11-08 2004-09-16 Assay method for identifying medicine for treatment of female sexual dysfunction (fsd), detecting method and kit for female sexual dysfunction, and non-human animal model of female sexual dysfunction
AU2005202166A AU2005202166A1 (en) 1999-11-08 2005-05-18 Compounds for the Treatment of Female Sexual Dysfunction
AU2005202750A AU2005202750A1 (en) 1999-11-08 2005-06-23 Compounds for the treatment of female sexual dysfunction
JP2005233224A JP2005350482A (en) 1999-11-08 2005-08-11 Compound for treatment of fsd

Publications (1)

Publication Number Publication Date
GB0016563D0 true GB0016563D0 (en) 2000-08-23

Family

ID=9895112

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0016563A Ceased GB0016563D0 (en) 2000-07-05 2000-07-05 Pharmaceutical

Country Status (1)

Country Link
GB (1) GB0016563D0 (en)

Similar Documents

Publication Publication Date Title
DE60136690D1 (en) Axiales wirbelimplantat
DE60119890D1 (en) Handfixierungsvorrichtung
DE60111019D1 (en) Penisprothese
DE60137350D1 (en) Bipolares ablationsgerät
DE60139107D1 (en) Substituierte phenyl-sulfamoyl-carboxamide
DE60105852D1 (en) Fluidmischsystem
DE60111057D1 (en) Intubationsinstrument
DE60140693D1 (en) Ankheiten
DE60138955D1 (en) Xanthin-phosphodiesteras-v-inhibitoren
DE60131671D1 (en) Abbaubare amorphe fluoroacrylat-polymere
DE60102572D1 (en) Polyurethanhartschaumstoffe
DE60131262D1 (en) Ubiquitin-ligase-assay
DE60123606D1 (en) Transkutane prothese
GB2358583B (en) Pharmaceutical compositions
EG24357A (en) New Pharmaceutical composition
DE60123472D1 (en) Holographische multifokallinse
DE60116761D1 (en) Adamantanderivate
DE60115644D1 (en) Thiazinoxazolidinon
DE60141333D1 (en) Ioxidlösung
DE50110048D1 (en) Härtbare wässrige polyurethandispersionen
DE60121590D1 (en) Pyrazolderivate
DE60144026D1 (en) Off-center-tomosynthese
DE60116104D1 (en) Phasendispersive tomographie
DE60115621D1 (en) Imidazolcarbene
DE50112082D1 (en) Bulk-acoustic-wave-filter

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)